Yoshihiko Aoki

457 total citations
22 papers, 285 citations indexed

About

Yoshihiko Aoki is a scholar working on Epidemiology, Hepatology and Immunology. According to data from OpenAlex, Yoshihiko Aoki has authored 22 papers receiving a total of 285 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 12 papers in Hepatology and 6 papers in Immunology. Recurrent topics in Yoshihiko Aoki's work include Liver Disease Diagnosis and Treatment (10 papers), Hepatitis C virus research (6 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). Yoshihiko Aoki is often cited by papers focused on Liver Disease Diagnosis and Treatment (10 papers), Hepatitis C virus research (6 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). Yoshihiko Aoki collaborates with scholars based in Japan, United States and Croatia. Yoshihiko Aoki's co-authors include Tatsuya Kanto, Masatoshi Imamura, Masashi Mizokami, Masaya Sugiyama, Sachiyo Yoshio, Kazumoto Murata, Naohiko Masaki, Masaaki Korenaga, Kiyoaki Ito and Hiroaki Saito and has published in prestigious journals such as Hepatology, Journal of Clinical Microbiology and Annals of Oncology.

In The Last Decade

Yoshihiko Aoki

22 papers receiving 279 citations

Peers

Yoshihiko Aoki

HEPAT

EPIDE

IMMUN

ONCOL

Barbara Lei Italy

Taizo Mori Japan

Shunsuke Shiba Japan

S. Bignulin Italy

S Tripi Italy

Yuki Tahata Japan

Yuzo Koda Japan

Maria Francesca Secchi Italy

Tomonori Senoh Japan

Feyza Gündüz Türkiye

Barbara Lei Italy

Yoshihiko Aoki

143 ×0.9

HEPAT

153 ×1.0

EPIDE

21 ×0.4

IMMUN

49 ×1.2

30 ×0.8

ONCOL

Citations per year, relative to Yoshihiko Aoki Yoshihiko Aoki (= 1×) peers Barbara Lei

Countries citing papers authored by Yoshihiko Aoki

Since Specialization

Citations

This map shows the geographic impact of Yoshihiko Aoki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshihiko Aoki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshihiko Aoki more than expected).

Fields of papers citing papers by Yoshihiko Aoki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshihiko Aoki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshihiko Aoki. The network helps show where Yoshihiko Aoki may publish in the future.

Co-authorship network of co-authors of Yoshihiko Aoki

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshihiko Aoki. A scholar is included among the top collaborators of Yoshihiko Aoki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshihiko Aoki. Yoshihiko Aoki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yoshio, Sachiyo, Taiji Yamazoe, Taizo Mori, et al.. (2024). Immunoglobulin-like transcript 2 as an impaired anti-tumor cytotoxicity marker of natural killer cells in patients with hepatocellular carcinoma. Frontiers in Immunology. 15. 1389411–1389411. 2 indexed citations

Kakazu, Eiji, Hiroko Matsubara, Keisuke Kakisaka, et al.. (2024). Comprehensive analysis of peripheral blood free amino acids in MASLD: the impact of glycine-serine-threonine metabolism. Amino Acids. 57(1). 3–3. 4 indexed citations

Aoki, Yoshihiko, Izuma Nakayama, Hirokazu Shoji, et al.. (2024). 500TiP An open label phase Ib/II study of trastuzumab deruxtecan (T-DXd) in combination with nivolumab and CAPOX for patients with HER2-low expressing gastroesophageal adenocarcinoma (EPOC2203). Annals of Oncology. 35. S199–S199. 2 indexed citations

Kakazu, Eiji, Hiroko Matsubara, Keisuke Kakisaka, et al.. (2024). Differences in branched-chain amino acid to tyrosine ratio (BTR) among etiologies of chronic liver disease progression compared to healthy adults.. Journal of Gastroenterology. 59(6). 483–493. 6 indexed citations

Kakazu, Eiji, Hisayuki Katsuyama, Mariko Hakoshima, et al.. (2023). Effects of sodium glucose cotransporter 2 inhibitors and pioglitazone on FIB‐4 index in metabolic‐associated fatty liver disease. Hepatology Research. 53(7). 618–628. 8 indexed citations

Mori, Taizo, Sachiyo Yoshio, Yuzuru Sakamoto, et al.. (2023). Toll‐like receptor 7 agonist, GS‐986, is an immune‐stimulant inducing follicular helper T cells and expanding HBs antigen‐specific B cells in vitro. Liver International. 43(6). 1213–1224. 5 indexed citations

Osawa, Yosuke, Sachiyo Yoshio, Yoshihiko Aoki, et al.. (2021). Blood angiopoietin-2 predicts liver angiogenesis and fibrosis in hepatitis C patients. BMC Gastroenterology. 21(1). 55–55. 14 indexed citations

Doi, Hiroyoshi, Sachiyo Yoshio, Hironari Kawai, et al.. (2019). Immune Determinants in the Acquisition and Maintenance of Antibody to Hepatitis B Surface Antigen in Adults After First‐Time Hepatitis B Vaccination. Hepatology Communications. 3(6). 812–824. 8 indexed citations

Mano, Yohei, Sachiyo Yoshio, Hirotaka Shoji, et al.. (2019). Bone morphogenetic protein 4 provides cancer-supportive phenotypes to liver fibroblasts in patients with hepatocellular carcinoma. Journal of Gastroenterology. 54(11). 1007–1018. 35 indexed citations

10.

Sakamoto, Yuzuru, Sachiyo Yoshio, Hiroyoshi Doi, et al.. (2019). Serum soluble sialic acid‐binding immunoglobulin‐like lectin‐7 concentration as an indicator of liver macrophage activation and advanced fibrosis in patients with non‐alcoholic fatty liver disease. Hepatology Research. 50(4). 466–477. 7 indexed citations

11.

Shoji, Hirotaka, Sachiyo Yoshio, Yohei Mano, et al.. (2017). Pro‐angiogenic TIE‐2‐expressing monocytes/TEMs as a biomarker of the effect of sorafenib in patients with advanced hepatocellular carcinoma. International Journal of Cancer. 141(5). 1011–1017. 6 indexed citations

12.

Korenaga, Keiko, Masaaki Korenaga, Masatoshi Imamura, et al.. (2015). Appropriate use of virtual touch quantification and FibroScan® M and XL probes according to the skin capsular distance. Journal of Gastroenterology. 51(5). 496–505. 23 indexed citations

13.

Aoki, Yoshihiko, Masaya Sugiyama, Kazumoto Murata, et al.. (2014). Association of serum IFN-λ3 with inflammatory and fibrosis markers in patients with chronic hepatitis C virus infection. Journal of Gastroenterology. 50(8). 894–902. 23 indexed citations

14.

Murata, Kazumoto, Masaya Sugiyama, Tatsuji Kimura, et al.. (2013). Ex vivo induction of IFN-λ3 by a TLR7 agonist determines response to Peg-IFN/Ribavirin therapy in chronic hepatitis C patients. Journal of Gastroenterology. 49(1). 126–137. 17 indexed citations

15.

Takeda, Tsutomu, Kazumoto Murata, Mami Ikeda, et al.. (2013). [Primary adenosquamous carcinoma of the liver presenting with hematochezia due to tumor invasion of the colon].. PubMed. 110(11). 1959–67. 4 indexed citations

16.

Saito, Hiroaki, Kiyoaki Ito, Masaya Sugiyama, et al.. (2012). Factors responsible for the discrepancy between IL28B polymorphism prediction and the viral response to peginterferon plus ribavirin therapy in Japanese chronic hepatitis C patients. Hepatology Research. 42(10). 958–965. 6 indexed citations

17.

Ito, Kiyoaki, Atsushi Kuno, Yuzuru Ikehara, et al.. (2012). LecT-hepa, a glyco-marker derived from multiple lectins, as a predictor of liver fibrosis in chronic hepatitis C patients. Hepatology. 56(4). 1448–1456. 27 indexed citations

18.

Ito, Kiyoaki, Naohiko Masaki, Masaya Sugiyama, et al.. (2011). The rs8099917 Polymorphism, When Determined by a Suitable Genotyping Method, Is a Better Predictor for Response to Pegylated Alpha Interferon/Ribavirin Therapy in Japanese Patients than Other Single Nucleotide Polymorphisms Associated with Interleukin-28B. Journal of Clinical Microbiology. 49(5). 1853–1860. 58 indexed citations

19.

Inai, Kei, et al.. (1985). Tumorigenicity study of butyl and isobutyl p-hydroxybenzoates administered orally to mice. Food and Chemical Toxicology. 23(6). 575–578. 22 indexed citations

20.

Aoki, Yoshihiko, et al.. (1983). Onchocercomas in Guatemala, with Special Reference to Appearance of New Nodules and Parasite Content. American Journal of Tropical Medicine and Hygiene. 32(4). 741–746. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact